Skip to main content
SpringerLink
Log in

Clinical Experiences with Budipine in Parkinson Therapy

  • Conference proceedings
  • © 1985

Overview

Editors:
  1. Franz Gerstenbrand

    1. Neurologische Universitätsklinik, Innsbruck, Austria

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Werner Poewe

    1. Neurologische Universitätsklinik, Innsbruck, Austria

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Gerald Stern

    1. Department of Neurology, University College Hospital, London, Great Britain

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (29 papers)

  1. Front Matter

    Pages I-XI
    Download chapter PDF

  2. James Parkinson and the Treatment of His Disease

    • G. Stern
    Pages 1-3

  3. Biochemical Neuropathology: A New Approach to Parkinson’s Disease

    • Y. Agid
    Pages 4-12

  4. Clinical Neurophysiology of Parkinson’s Disease

    • P. J. Delwaide, M. Gonce
    Pages 13-21

  5. Dopaminergic Agonists and Receptors: Their Relevance to the Treatment of Parkinson’s Disease

    • D. B. Calne, T. A. Larsen
    Pages 22-30

  6. Brain Dopaminergic Receptor Changes in Parkinson’s Disease in Relation to the Disease Process and Treatment

    • U. K. Rinne, J. O. Rinne, J. K. Rinne, K. Laakso
    Pages 31-39

  7. Analysis of Akinesia

    • H. Narabayashi
    Pages 40-43

  8. Observations on Voluntarily Induced Automatic Motor Behaviour in Parkinsonism

    • J. P. W. F. Lakke, W. van den Burg
    Pages 44-51

  9. Significance of Mental Disorders in the Long-Term Treatment of Parkinson’s Disease

    • P.-A. Fischer
    Pages 52-57

  10. Treatment of Parkinson’s Disease in Early and Late Phases

    • M. Yahr
    Pages 58-67

  11. Relevance of Dopaminergic Agonists and Antagonists to Parkinsonian Tremor

    • S. Ruggieri, A. Denaro, M. Baldassarre, F. Stocchi, A. Agnoli
    Pages 68-72

  12. Therapeutic Possibilities in On-Off Phenomena in Parkinson’s Disease

    • E. Csanda, M. Tárczy
    Pages 73-78

  13. Target and Additive Drugs in the Treatment of Parkinson’s Disease: A Pilot Study

    • W. Birkmayer, P. Riederer
    Pages 79-81

  14. Pharmacologic Bases of Antiparkinsonian Therapy

    • H. G. Menge, U. Brand
    Pages 82-92

  15. The Pharmacodynamics of Budipine on Central Neurotransmitter Systems

    • J. Offermeier, J. M. van Rooyen
    Pages 93-106

  16. Biochemical and Pharmacologic Aspects of the Mechanism of Action of Budipine

    • H. Przuntek, J.-P. Stasch
    Pages 107-112

  17. Pharmacokinetics and Metabolism of Budipine in Animals and Humans

    • K. Zech, E. Sturm, G. Ludwig
    Pages 113-121

  18. Clinical Experience with Budipine in Parkinsonian Therapy

    • W. Poewe, F. Gerstenbrand, G. Ransmayr
    Pages 122-128

  19. Controlled Single-Blind Trial of Budipine, L-Dopa, and Amantadine in 102 Patients with Parkinson’s Disease

    • J. Iizuka
    Pages 129-139

  20. Open Clinical Trial of Budipine in 25 Tremor-Dominant Parkinsonian Patients

    • E. Ketz
    Pages 140-141
Back to top

Keywords

Editors and Affiliations

  • Neurologische Universitätsklinik, Innsbruck, Austria

    Franz Gerstenbrand, Werner Poewe

  • Department of Neurology, University College Hospital, London, Great Britain

    Gerald Stern

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation